PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC.

MLA

Chen, Xiuqiong, et al. “PIM1/NF-ΚB/CCL2 Blockade Enhances Anti-PD-1 Therapy Response by Modulating Macrophage Infiltration and Polarization in Tumor Microenvironment of NSCLC.” Oncogene, vol. 43, no. 33, Aug. 2024, pp. 2517–30. EBSCOhost, https://doi.org/10.1038/s41388-024-03100-6.

APA

Chen, X., Zhou, J., Wang, Y., Wang, X., Chen, K., Chen, Q., Huang, D., & Jiang, R. (2024). PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC. Oncogene, 43(33), 2517–2530. https://doi.org/10.1038/s41388-024-03100-6

Chicago

Chen, Xiuqiong, Jing Zhou, Youhui Wang, Xinyue Wang, Kaidi Chen, Qin Chen, Dingzhi Huang, and Richeng Jiang. 2024. “PIM1/NF-ΚB/CCL2 Blockade Enhances Anti-PD-1 Therapy Response by Modulating Macrophage Infiltration and Polarization in Tumor Microenvironment of NSCLC.” Oncogene 43 (33): 2517–30. doi:10.1038/s41388-024-03100-6.